Cargando…
Kallikrein gene family as biomarkers for recurrent prostate cancer
AIM: To assess kallikrein (KLK) expression in recurrent and non-recurrent prostate tumors and adjacent healthy prostate tissues. METHODS: The expression levels of 15 KLK genes in 34 recurrent and 36 non-recurrent prostate cancer samples and 19 adjacent healthy prostate tissue samples was assessed wi...
Autores principales: | Busra Boyukozer, Fatma, Guzel Tanoglu, Esra, Ozen, Mustafa, Ittmann, Michael, Sibel Aslan, Elif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684543/ https://www.ncbi.nlm.nih.gov/pubmed/33150763 http://dx.doi.org/10.3325/cmj.2020.61.450 |
Ejemplares similares
-
miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer
por: Karatas, Omer Faruk, et al.
Publicado: (2014) -
Kallikreins as Biomarkers for Prostate Cancer
por: Hong, Sung Kyu
Publicado: (2014) -
Differential expressions of miR-223, miR-424, miR-145, miR-200c, miR-139 in experimental rat chronic pancreatitis model and their relationship between oxidative stress, endoplasmic reticulum stress, and apoptosis
por: Tanoglu, Esra Guzel
Publicado: (2021) -
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
por: Tailor, Prashant D., et al.
Publicado: (2018) -
A novel FLCN mutation in family members diagnosed with primary spontaneous pneumothorax
por: Genc Yavuz, Burcu, et al.
Publicado: (2019)